MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$44,270
Net loss
-$4,937,046
Total other income
(expense)
$38,159
Interest expense
$6,111
Loss from operations
-$4,975,205
Total operating
expenses
$4,975,205
Research and development
$3,543,723
General and
administrative
$1,431,482
Back
Back
Income Statement
source: myfinsight.com
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)